NCT05891171
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05891171
Title Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers (ARC-25)
Acronym ARC-25
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
Lake City Cancer Care, LLC. Lake City Florida 32024 United States Details
Affinity Health Hope and Healing Cancer Services, LLC Hinsdale Illinois 60521 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
Gabrail Cancer Center (GCC) Canton Facility Canton Ohio 44718 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Next Oncology Dallas Irving Texas 75039 United States Details
Next Oncology Virginia Fairfax Virginia 22031 United States Details
Adelaide Cancer Research Adelaide Australia Details
Queen Elizabeth Hospital Adelaide Australia Details
National Cheng Kung University Hospital Tainan Taiwan Details
Taipei Veterans General Hospital Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field